This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $422,569 to Vanderbilt University for the development of new chemical reactions and reagents to generate enantioenriched organic compounds. The overarching goal is to enable the concise synthesis of secondary amines, tertiary amines, and vicinal diamines as single stereoisomers, which are valuable precursors for small molecule therapeutic agents and biologically active natural products. The proposed methods involve the use of bis(amidine) reagents that form chiral proton complexes, as well as the exploration of a new catalyst design using achiral Brønsted acid activators. The project aims to develop innovative multicomponent coupling reactions that leverage chiral proton catalysis to control enantioselectivity, with the potential to impact small molecule synthesis and therapeutic agent development. This 5-year project is set to begin on May 1, 2025 and conclude on April 30, 2030.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $422.6k | 4/23/25 |